G1 Therapeutics GTHX reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
G1 Therapeutics beat estimated earnings by 6.35%, reporting an EPS of $-0.59 versus an estimate of $-0.63.
Revenue was up $18.72 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.1 which was followed by a 20.16% increase in the share price the next day.
Here's a look at G1 Therapeutics's past performance:
Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
---|---|---|---|---|
EPS Estimate | -1.02 | -0.97 | -1.03 | -1 |
EPS Actual | -0.92 | -1.15 | -0.94 | -1 |
Revenue Estimate | 9.14M | 6.69M | 5.68M | 5.18M |
Revenue Actual | 10.57M | 6.90M | 5.80M | 4.86M |
To track all earnings releases for G1 Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.